BioMarin Pharmaceutical Inc.
Price Action
Technical Summary
WEAKENINGBioMarin Pharmaceutical Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 34), showing significant lag compared to the market leaders. Earnings contraction of 43% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $54.43 | +0.31% | ABOVE |
| 50 SMA | $56.38 | -3.15% | BELOW |
| 100 SMA | $57.22 | -4.57% | BELOW |
| 150 SMA | $56.08 | -2.64% | BELOW |
| 200 SMA | $56.32 | -3.05% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BMRN in an uptrend right now?
BMRN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is BMRN overbought or oversold?
BMRN's RSI (14) is 42. The stock is in neutral territory, neither overbought nor oversold.
Is BMRN outperforming the market?
BMRN has a Relative Strength (RS) Rating of 34 out of 99. BMRN is currently lagging the broader market.
Where is BMRN in its 52-week range?
BMRN is trading at $54.60, which is 82% of its 52-week high ($66.28) and 25% above its 52-week low ($50.76).
How volatile is BMRN?
BMRN has a Beta of 0.65 and 52-week volatility of 32%. It's less volatile than the S&P 500 - generally more stable.